BioBrit — 2015 Investments
1 investments dated 2015 · listed companies and verified rows first · show all
AnaptysBioanaptysbio.cominNASDAQ: ANABJul 2015
AnaptysBio manages the financial collaborations from Jemperli (with GSK) and imsidolimab (with Vanda), operating a virtual model focused on protecting and returning royalty and milestone value to stockholders.
BiotechSan Diego, US
Robert Hoffman(Executive Officer)Marco Londei(Executive Officer)Hamza Suria(Executive Officer, Director)Daniel Faga(President, CEO, and Director)Christopher Murphy(CFO)
BoardCarol Gallagher(Director)
Co-investorsFrazier Life SciencesNorwest Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.